National Health Act (Pharmaceutical Benefits – Early Supply) Amendment, June 2009 specification under subsection 84AAA(2) (No. PB 45 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 45 of 2009

National Health (Pharmaceutical Benefits – Early Supply) Amendment, June 2009 - Specification Under Subsection 84AAA(2)

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

I, Linda Jackson, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated          22      May 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination — Pharmaceutical Benefits-Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment, June 2009 - specification under subsection 84AAA(2).

(2)      This Instrument may also be cited as “No. PB 45 of 2009”.

2          Commencement

This Instrument commences on 1 June 2009.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

Schedule 1        Amendments

1. Schedule 1, item dealing with Efalizumab

omit from the columns in the order indicated:

Efalizumab Injection set containing 4 vials powder for injection 125 mg and 4 pre-filled syringes diluent 1.3 mL Injection 1 5

1. Schedule 1, item dealing with Oestrogens--conjugated with medroxyprogesterone

omit from the columns in the order indicated:

Oestrogens--conjugated with medroxyprogesterone	Tablets containing conjugated oestrogens 625 micrograms with medroxyprogesterone acetate 2.5 mg, 28	Oral	1	5
	Tablets containing conjugated oestrogens 625 micrograms with medroxyprogesterone acetate 5 mg, 28	Oral	1	5

1. Schedule 1, item dealing with Pantoprazole

insert in the columns before item dealing with Tablet (enteric coated) 20 mg (as sodium sesquihydrate):

Sachet containing granules 40 mg (as sodium sesquihydate) Oral 30 5

1. Schedule 1, item dealing with Phenoxybenzamine

insert in the columns after item dealing with Capsule containing phenoxybenzamine hydrochloride 10 mg:

Capsules containing phenoxybenzamine hydrochloride 10 mg, 100 Oral 1 5

1. Schedule 1, after item dealing with Risedronate sodium and calcium carbonate

insert in the columns in the order indicated:

Risedronate sodium and calcium carbonate with colecalciferol Pack containing 4 tablets risedornate sodium 35 mg and 24 sachets containing granules of calcium carbonate 2.5 g (equivalent to 1 g calcium) with colecalciferol 22 micrograms Oral 1 5